Home › Stocks › CCRN › All Fund Holders
CCRN — CROSS COUNTRY HEALTHCARE INC · All Fund Holders
Funds holding (latest): 47 · Reported value held: $158.57M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 2.75M | $36.33M | 0.00% | Add |
| Fidelity International (FIL) history | Q2 2026 | 1.29M | $17.07M | 0.01% | New |
| Vanguard Group history | Q4 2025 | 1.90M | $15.42M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 912.38K | $12.05M | 0.01% | New |
| Geode Capital Management history | Q2 2026 | 804.29K | $10.63M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 786.52K | $10.39M | 0.00% | Reduce |
| First Eagle Investment Management history | Q2 2026 | 747.28K | $9.87M | 0.02% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 492.65K | $6.51M | 0.00% | Reduce |
| Wellington Management Group history | Q1 2024 | 345.86K | $6.47M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 293.99K | $3.88M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 282.53K | $3.73M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 278.38K | $3.68M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 233.75K | $3.09M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 169.56K | $2.24M | 0.00% | Add |
| Norges Bank Investment Management history | Q4 2024 | 111.60K | $2.03M | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 152.68K | $2.02M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 117.35K | $1.55M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 89.06K | $1.18M | 0.00% | Add |
| MFS Investment Management history | Q2 2023 | 41.54K | $1.17M | 0.00% | Reduce |
| Moore Capital Management history | Q4 2025 | 127.34K | $1.03M | 0.01% | Reduce |
| Franklin Resources history | Q2 2026 | 72.97K | $963.91K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 70.99K | $937.80K | 0.00% | Reduce |
| PSP Investments history | Q3 2024 | 67.43K | $906.22K | 0.01% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 42.07K | $555.75K | 0.00% | New |
| Lazard Asset Management history | Q1 2026 | 58.17K | $546.78K | 0.00% | Add |
| Balyasny Asset Management history | Q1 2026 | 55.72K | $523.74K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 29.70K | $392.31K | 0.00% | Add |
| Principal Global Investors history | Q4 2025 | 47.75K | $386.80K | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 38.13K | $358.44K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 25.71K | $339.68K | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 21.26K | $280.86K | 0.00% | Reduce |
| Arrowstreet Capital history | Q2 2026 | 20.76K | $274.24K | 0.00% | New |
| Prudential Financial history | Q4 2024 | 13.81K | $250.88K | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 17.00K | $224.57K | 0.00% | Reduce |
| Janus Henderson Group history | Q2 2025 | 15.23K | $198.68K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 14.40K | $190.18K | 0.00% | Reduce |
| Bridgewater Associates history | Q3 2024 | 13.93K | $187.23K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 14.05K | $185.64K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 10.94K | $144.54K | 0.00% | Reduce |
| Royce & Associates history | Q2 2026 | 10.79K | $142.54K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 6.19K | $81.82K | 0.00% | Add |
| Manulife Financial history | Q4 2025 | 10.10K | $81.79K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 4.56K | $60.20K | 0.00% | Reduce |
| CPP Investments history | Q4 2025 | 2.20K | $17.82K | 0.00% | New |
| BROWN BROTHERS HARRIMAN & CO history | Q2 2026 | 100 | $1.32K | 0.00% | New |
| Amundi US history | Q1 2025 | 69 | $1.02K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 35.25K | $466 | 0.00% | Add |